Transdermal/Transmucosal Drug Delivery System Market Insights, Global Outlook and Forecast 2022-2028
Transdermal/Transmucosal Drug Delivery System Market Insights, Global Outlook and Forecast 2022-2028
The research report on ‘Transdermal Transmucosal Drug Delivery System Market’ provides a workplan for stakeholders for the estimated timeframe of -. To elaborate, it offers valid predictions for the size, shares, and growth patterns of this domain over the projected timeline by assessing the past records and present business trends.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
Transdermal/transmucosal drug delivery is a well-established accepted route of administration for therapeutically beneficial medicines. Transdermal/transmucosal drug delivery continues to play an important role in the development of a variety of therapeutic areas in both brand and generic products.
The latest research study released by Market IntelliX evaluates market size and forecasts of Transdermal/Transmucosal Drug Delivery System in global, including the following market information:
Global Transdermal/Transmucosal Drug Delivery System Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Transdermal/Transmucosal Drug Delivery System Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Transdermal/Transmucosal Drug Delivery System companies in 2021 (%)
The global Transdermal/Transmucosal Drug Delivery System market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Transdermal Drug Delivery System Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Transdermal/Transmucosal Drug Delivery System include 3M, Antares Pharma, Aveva Drug Delivery Systems, Corium International, DURECT, Pantec Biosolutions, Tapemark, Tesa Labtec and Mylan, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MI has surveyed the Transdermal/Transmucosal Drug Delivery System manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Market Segmentations:
Global Transdermal/Transmucosal Drug Delivery System Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Transdermal/Transmucosal Drug Delivery System Market Segment Percentages, by Type, 2021 (%)
Transdermal Drug Delivery System
Transmucosal Drug Delivery System
Global Transdermal/Transmucosal Drug Delivery System Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Transdermal/Transmucosal Drug Delivery System Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Others
Global Transdermal/Transmucosal Drug Delivery System Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Transdermal/Transmucosal Drug Delivery System Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Transdermal/Transmucosal Drug Delivery System revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Transdermal/Transmucosal Drug Delivery System revenues share in global market, 2021 (%)
Key companies Transdermal/Transmucosal Drug Delivery System sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Transdermal/Transmucosal Drug Delivery System sales share in global market, 2021 (%)
The report presents profiles of competitors in the market, Some of the prominent key players covered:
3M
Antares Pharma
Aveva Drug Delivery Systems
Corium International
DURECT
Pantec Biosolutions
Tapemark
Tesa Labtec
Mylan
Teva
Zosano Pharma
Key Takeaways from this Report
Evaluate market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level – for product types, end use applications and by different industry verticals.
Understand the different dynamics influencing the market – key driving factors, challenges and hidden opportunities.
Get in-depth insights on your competitor performance – market shares, strategies, financial benchmarking, product benchmarking, SWOT and more.
Analyze the sales and distribution channels across key geographies to improve top-line revenues.
Understand the industry supply chain with a deep-dive on the value augmentation at each step, in order to optimize value and bring efficiencies in your processes.
Get a quick outlook on the market entropy – M&A’s, deals, partnerships, product launches of all key players for the past 4 years.
Evaluate the supply-demand gaps, import-export statistics and regulatory landscape for more than top 20 countries globally for the market.
1 Introduction to Research & Analysis Reports
1.1 Transdermal/Transmucosal Drug Delivery System Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Transdermal/Transmucosal Drug Delivery System Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Transdermal/Transmucosal Drug Delivery System Overall Market Size
2.1 Global Transdermal/Transmucosal Drug Delivery System Market Size: 2021 VS 2028
2.2 Global Transdermal/Transmucosal Drug Delivery System Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Transdermal/Transmucosal Drug Delivery System Sales: 2017-2028
3 Company Landscape
3.1 Top Transdermal/Transmucosal Drug Delivery System Players in Global Market
3.2 Top Global Transdermal/Transmucosal Drug Delivery System Companies Ranked by Revenue
3.3 Global Transdermal/Transmucosal Drug Delivery System Revenue by Companies
3.4 Global Transdermal/Transmucosal Drug Delivery System Sales by Companies
3.5 Global Transdermal/Transmucosal Drug Delivery System Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Transdermal/Transmucosal Drug Delivery System Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Transdermal/Transmucosal Drug Delivery System Product Type
3.8 Tier 1, Tier 2 and Tier 3 Transdermal/Transmucosal Drug Delivery System Players in Global Market
3.8.1 List of Global Tier 1 Transdermal/Transmucosal Drug Delivery System Companies
3.8.2 List of Global Tier 2 and Tier 3 Transdermal/Transmucosal Drug Delivery System Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Transdermal/Transmucosal Drug Delivery System Market Size Markets, 2021 & 2028
4.1.2 Transdermal Drug Delivery System
4.1.3 Transmucosal Drug Delivery System
4.2 By Type - Global Transdermal/Transmucosal Drug Delivery System Revenue & Forecasts
4.2.1 By Type - Global Transdermal/Transmucosal Drug Delivery System Revenue, 2017-2022
4.2.2 By Type - Global Transdermal/Transmucosal Drug Delivery System Revenue, 2023-2028
4.2.3 By Type - Global Transdermal/Transmucosal Drug Delivery System Revenue Market Share, 2017-2028
4.3 By Type - Global Transdermal/Transmucosal Drug Delivery System Sales & Forecasts
4.3.1 By Type - Global Transdermal/Transmucosal Drug Delivery System Sales, 2017-2022
4.3.2 By Type - Global Transdermal/Transmucosal Drug Delivery System Sales, 2023-2028
4.3.3 By Type - Global Transdermal/Transmucosal Drug Delivery System Sales Market Share, 2017-2028
4.4 By Type - Global Transdermal/Transmucosal Drug Delivery System Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Transdermal/Transmucosal Drug Delivery System Market Size, 2021 & 2028
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Others
5.2 By Application - Global Transdermal/Transmucosal Drug Delivery System Revenue & Forecasts
5.2.1 By Application - Global Transdermal/Transmucosal Drug Delivery System Revenue, 2017-2022
5.2.2 By Application - Global Transdermal/Transmucosal Drug Delivery System Revenue, 2023-2028
5.2.3 By Application - Global Transdermal/Transmucosal Drug Delivery System Revenue Market Share, 2017-2028
5.3 By Application - Global Transdermal/Transmucosal Drug Delivery System Sales & Forecasts
5.3.1 By Application - Global Transdermal/Transmucosal Drug Delivery System Sales, 2017-2022
5.3.2 By Application - Global Transdermal/Transmucosal Drug Delivery System Sales, 2023-2028
5.3.3 By Application - Global Transdermal/Transmucosal Drug Delivery System Sales Market Share, 2017-2028
5.4 By Application - Global Transdermal/Transmucosal Drug Delivery System Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Transdermal/Transmucosal Drug Delivery System Market Size, 2021 & 2028
6.2 By Region - Global Transdermal/Transmucosal Drug Delivery System Revenue & Forecasts
6.2.1 By Region - Global Transdermal/Transmucosal Drug Delivery System Revenue, 2017-2022
6.2.2 By Region - Global Transdermal/Transmucosal Drug Delivery System Revenue, 2023-2028
6.2.3 By Region - Global Transdermal/Transmucosal Drug Delivery System Revenue Market Share, 2017-2028
6.3 By Region - Global Transdermal/Transmucosal Drug Delivery System Sales & Forecasts
6.3.1 By Region - Global Transdermal/Transmucosal Drug Delivery System Sales, 2017-2022
6.3.2 By Region - Global Transdermal/Transmucosal Drug Delivery System Sales, 2023-2028
6.3.3 By Region - Global Transdermal/Transmucosal Drug Delivery System Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Transdermal/Transmucosal Drug Delivery System Revenue, 2017-2028
6.4.2 By Country - North America Transdermal/Transmucosal Drug Delivery System Sales, 2017-2028
6.4.3 US Transdermal/Transmucosal Drug Delivery System Market Size, 2017-2028
6.4.4 Canada Transdermal/Transmucosal Drug Delivery System Market Size, 2017-2028
6.4.5 Mexico Transdermal/Transmucosal Drug Delivery System Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Transdermal/Transmucosal Drug Delivery System Revenue, 2017-2028
6.5.2 By Country - Europe Transdermal/Transmucosal Drug Delivery System Sales, 2017-2028
6.5.3 Germany Transdermal/Transmucosal Drug Delivery System Market Size, 2017-2028
6.5.4 France Transdermal/Transmucosal Drug Delivery System Market Size, 2017-2028
6.5.5 U.K. Transdermal/Transmucosal Drug Delivery System Market Size, 2017-2028
6.5.6 Italy Transdermal/Transmucosal Drug Delivery System Market Size, 2017-2028
6.5.7 Russia Transdermal/Transmucosal Drug Delivery System Market Size, 2017-2028
6.5.8 Nordic Countries Transdermal/Transmucosal Drug Delivery System Market Size, 2017-2028
6.5.9 Benelux Transdermal/Transmucosal Drug Delivery System Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Transdermal/Transmucosal Drug Delivery System Revenue, 2017-2028
6.6.2 By Region - Asia Transdermal/Transmucosal Drug Delivery System Sales, 2017-2028
6.6.3 China Transdermal/Transmucosal Drug Delivery System Market Size, 2017-2028
6.6.4 Japan Transdermal/Transmucosal Drug Delivery System Market Size, 2017-2028
6.6.5 South Korea Transdermal/Transmucosal Drug Delivery System Market Size, 2017-2028
6.6.6 Southeast Asia Transdermal/Transmucosal Drug Delivery System Market Size, 2017-2028
6.6.7 India Transdermal/Transmucosal Drug Delivery System Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Transdermal/Transmucosal Drug Delivery System Revenue, 2017-2028
6.7.2 By Country - South America Transdermal/Transmucosal Drug Delivery System Sales, 2017-2028
6.7.3 Brazil Transdermal/Transmucosal Drug Delivery System Market Size, 2017-2028
6.7.4 Argentina Transdermal/Transmucosal Drug Delivery System Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Transdermal/Transmucosal Drug Delivery System Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Transdermal/Transmucosal Drug Delivery System Sales, 2017-2028
6.8.3 Turkey Transdermal/Transmucosal Drug Delivery System Market Size, 2017-2028
6.8.4 Israel Transdermal/Transmucosal Drug Delivery System Market Size, 2017-2028
6.8.5 Saudi Arabia Transdermal/Transmucosal Drug Delivery System Market Size, 2017-2028
6.8.6 UAE Transdermal/Transmucosal Drug Delivery System Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 3M
7.1.1 3M Corporate Summary
7.1.2 3M Business Overview
7.1.3 3M Transdermal/Transmucosal Drug Delivery System Major Product Offerings
7.1.4 3M Transdermal/Transmucosal Drug Delivery System Sales and Revenue in Global (2017-2022)
7.1.5 3M Key News
7.2 Antares Pharma
7.2.1 Antares Pharma Corporate Summary
7.2.2 Antares Pharma Business Overview
7.2.3 Antares Pharma Transdermal/Transmucosal Drug Delivery System Major Product Offerings
7.2.4 Antares Pharma Transdermal/Transmucosal Drug Delivery System Sales and Revenue in Global (2017-2022)
7.2.5 Antares Pharma Key News
7.3 Aveva Drug Delivery Systems
7.3.1 Aveva Drug Delivery Systems Corporate Summary
7.3.2 Aveva Drug Delivery Systems Business Overview
7.3.3 Aveva Drug Delivery Systems Transdermal/Transmucosal Drug Delivery System Major Product Offerings
7.3.4 Aveva Drug Delivery Systems Transdermal/Transmucosal Drug Delivery System Sales and Revenue in Global (2017-2022)
7.3.5 Aveva Drug Delivery Systems Key News
7.4 Corium International
7.4.1 Corium International Corporate Summary
7.4.2 Corium International Business Overview
7.4.3 Corium International Transdermal/Transmucosal Drug Delivery System Major Product Offerings
7.4.4 Corium International Transdermal/Transmucosal Drug Delivery System Sales and Revenue in Global (2017-2022)
7.4.5 Corium International Key News
7.5 DURECT
7.5.1 DURECT Corporate Summary
7.5.2 DURECT Business Overview
7.5.3 DURECT Transdermal/Transmucosal Drug Delivery System Major Product Offerings
7.5.4 DURECT Transdermal/Transmucosal Drug Delivery System Sales and Revenue in Global (2017-2022)
7.5.5 DURECT Key News
7.6 Pantec Biosolutions
7.6.1 Pantec Biosolutions Corporate Summary
7.6.2 Pantec Biosolutions Business Overview
7.6.3 Pantec Biosolutions Transdermal/Transmucosal Drug Delivery System Major Product Offerings
7.6.4 Pantec Biosolutions Transdermal/Transmucosal Drug Delivery System Sales and Revenue in Global (2017-2022)
7.6.5 Pantec Biosolutions Key News
7.7 Tapemark
7.7.1 Tapemark Corporate Summary
7.7.2 Tapemark Business Overview
7.7.3 Tapemark Transdermal/Transmucosal Drug Delivery System Major Product Offerings
7.7.4 Tapemark Transdermal/Transmucosal Drug Delivery System Sales and Revenue in Global (2017-2022)
7.7.5 Tapemark Key News
7.8 Tesa Labtec
7.8.1 Tesa Labtec Corporate Summary
7.8.2 Tesa Labtec Business Overview
7.8.3 Tesa Labtec Transdermal/Transmucosal Drug Delivery System Major Product Offerings
7.8.4 Tesa Labtec Transdermal/Transmucosal Drug Delivery System Sales and Revenue in Global (2017-2022)
7.8.5 Tesa Labtec Key News
7.9 Mylan
7.9.1 Mylan Corporate Summary
7.9.2 Mylan Business Overview
7.9.3 Mylan Transdermal/Transmucosal Drug Delivery System Major Product Offerings
7.9.4 Mylan Transdermal/Transmucosal Drug Delivery System Sales and Revenue in Global (2017-2022)
7.9.5 Mylan Key News
7.10 Teva
7.10.1 Teva Corporate Summary
7.10.2 Teva Business Overview
7.10.3 Teva Transdermal/Transmucosal Drug Delivery System Major Product Offerings
7.10.4 Teva Transdermal/Transmucosal Drug Delivery System Sales and Revenue in Global (2017-2022)
7.10.5 Teva Key News
7.11 Zosano Pharma
7.11.1 Zosano Pharma Corporate Summary
7.11.2 Zosano Pharma Transdermal/Transmucosal Drug Delivery System Business Overview
7.11.3 Zosano Pharma Transdermal/Transmucosal Drug Delivery System Major Product Offerings
7.11.4 Zosano Pharma Transdermal/Transmucosal Drug Delivery System Sales and Revenue in Global (2017-2022)
7.11.5 Zosano Pharma Key News
8 Global Transdermal/Transmucosal Drug Delivery System Production Capacity, Analysis
8.1 Global Transdermal/Transmucosal Drug Delivery System Production Capacity, 2017-2028
8.2 Transdermal/Transmucosal Drug Delivery System Production Capacity of Key Manufacturers in Global Market
8.3 Global Transdermal/Transmucosal Drug Delivery System Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Transdermal/Transmucosal Drug Delivery System Supply Chain Analysis
10.1 Transdermal/Transmucosal Drug Delivery System Industry Value Chain
10.2 Transdermal/Transmucosal Drug Delivery System Upstream Market
10.3 Transdermal/Transmucosal Drug Delivery System Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Transdermal/Transmucosal Drug Delivery System Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
Research Methodology:
Transdermal Transmucosal Drug Delivery System Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|